InsidersTradesSigma
Follow the Aspire Biopharma Holdings, Inc. share price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). The latest transaction was reported on 10 June 2025 (Acquisition). Among the most active insiders: Fell Donald G.. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Aspire Biopharma Holdings, Inc. is a company focused on developing biopharmaceutical treatments. It is listed on the XNAS market.